Study summary · research use only
NMR solution structure of a peptide from the mdm-2 binding domain of the p53 protein that is selectively cytotoxic to cancer cells
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This study used two-dimensional NMR to determine the solution structure of PNC-27, a 32-residue peptide from the mdm-2 binding domain of the p53 protein that the authors had previously found induced membranolytic necrosis in human cancer cell lines. They report that in an aqueous, cytosol-like environment PNC-27 formed three alpha-helical domains connected by loops in an S shape, and in a membrane-mimetic environment the helices lengthened into a U-shaped helix-coil-helix arrangement. In both solvents the peptide formed amphipathic structures with hydrophobic and polar residues on opposite faces. The authors propose that this structural behavior may allow PNC-27 to disrupt cancer-cell membranes selectively.
Abstract
We have recently found that a peptide from the mdm-2 binding domain of the p53 protein induced rapid membranolytic necrosis of a variety of different human cancer cell lines. To determine the role of solution structure in this peptide's selective and rapid tumor membrane disruptive behavior, we have performed two-dimensional NMR on a 32-residue sequence called PNC-27, in both an aqueous cytosolic-like and a mixed organic membrane-mimetic solution environment. In an aqueous milieu, PNC-27 contains three alpha-helical domains connected by loop structures, forming an S shape, and another similar structure with less helical structure. In a solution environment simulating a membrane, the helical domains found in water increase in length, forming three classes of structures, all of which form a U-shaped helix-coil-helix ensemble. In both solvent systems, this peptide forms amphipathic structures such that its hydrophobic residues coalesce on one face while the polar residues aggregate on the opposite face. The ability to form these unique structures in these two solution environments may allow the PNC-27 peptide to selectively and rapidly disrupt cancer cell membranes.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.